Dynamic reorganization of the cytoskeleton is essential for numerous cellular processes including leukocyte migration. This process presents a substantial bioenergetic challenge to migrating cells as actin polymerization is dependent on ATP hydrolysis. Hence, migrating cells must increase ATP production to meet the increased metabolic demands of cytoskeletal reorganization. Despite this long-standing evidence, the metabolic regulation of leukocyte motility and trafficking has only recently begun to be investigated. In this review, we will summarize current knowledge of the crosstalk between cell metabolism and the cytoskeleton in leukocytes, and discuss the concept that leukocyte metabolism may reprogram in response to migratory stimuli and the different environmental cues received during recirculation ultimately regulating leukocyte motility and migration.
INTRODUCTION
In order to fulfill their effector and patrolling functions, leukocytes traffic through the body and need to adapt to different tissue microenvironments. First, differentiated leukocytes egress the bone marrow into the vascular system. Circulating leukocytes can exit the vasculature and penetrate into the tissues, either for patrolling in search for pathogens (i.e. resident monocytes, T cells) or to eliminate infection and activate the adaptive immune response (i.e. inflammatory monocytes, neutrophils).
The eukaryotic cytoskeleton is mainly composed of actin filaments, microtubules and intermediate filaments. These three constituents act coordinately to increase tensile strength, allow cell motility, maintain plasma integrity, participate in cell division, contribute to cell morphology and provide a network for cellular transport. 1 Leukocyte migration is dependent on a coordinated cytoskeleton reorganization response to promigratory stimuli initiated by adhesion Abbreviations: ACC-1, acetyl-CoA carboxylase; AMPK, adenosine monophosphate-activated protein kinase; DC, dendritic cell; FOXO, forkhead box protein O; GSK, glycogen synthase kinase; GCK, glucokinase; HIF-1 , hypoxia-inducible factor-1 ; mTOR, mechanistic target of rapamycin; OXPHOS, oxidative phosphorylation; PDK1, pyruvate dehydrogenase kinase 1; PKM2, pyruvate kinase M2; PFK, phosphofructokinase; PK, pyruvate kinase; PFKFB3, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3; PMN, polymorphonuclear leukocyte; SLO, secondary lymphoid organ; Treg, regulatory T cell and chemokine receptors, which is largely sustained by ATP and GTP hydrolysis for actin and tubulin reorganization into respectively. How leukocytes meet the increased energy demand during migration has only recently begun to be investigated. A key finding underlying these recent advances is the appreciation that, like cancer cells, immune cells can exhibit the "Warburg effect,"
i.e. a metabolic status characterized by a high rate of glucose utilization and lactate production despite the presence of sufficient oxygen to oxidize glucose carbon in the mitochondria. 2, 3 The Warburg effect is also observed during leukocyte proliferation, and it is nowadays viewed as a general feature of anabolic metabolism contributing to cell division.
Resting immune cells utilize energetically efficient processes compared to activated cells, such as the TCA cycle, linked to the generation of ATP via oxidative phosphorylation (OXPHOS). 4 Upon activation, IFN--stimulated macrophages (M1 spectrum) and antigen-activated T cells rapidly shift to aerobic glycolysis, whereas both IL-4-stimulated macrophages (M2 spectrum) and induced regulatory T cells mainly rely on oxidative phosphorylation. 5 Importantly, the metabolic status of immune cells can undergo reprogramming in response to environmental stimuli. When glycolysis is inhibited by modulation of key enzymes such as pyruvate kinase M2 (PKM2), 6 macrophages undergo a shift toward a more M2-like state in terms of gene expression and boost, for example, IL-10 production. A similar effect is observed in Th17 cells, which become more like Treg cells if glycolysis is inhibited with 2-deoxyglucose or if hypoxia-inducible factor-1 (HIF-1 ), a master transcriptional regulator of cellular responses to hypoxia and potent glycolysis inducer is ablated. 7 The plasticity of leukocyte metabolism is required to accommodate their metabolic needs to the availability of nutrients. The mechanistic target of rapamycin (mTOR) pathway is central to the regulation of metabolic processes and their adaptation. 8 
mTOR exists
as two structurally distinct complexes (mTORC1 and mTORC2). Both complexes localize within different subcellular compartments and have different functions in the cell; rapamycin-sensitive mTORC1 forms the fundamental nutrient sensing complex that is activated by Akt kinase downstream of phosphoinositide 3-kinase (PI3K) signaling induction whereas the rapamycin-insensitive mTORC2 controls spatial aspects of cell growth through activation of cytoskeletal components. 9, 10 The mTORC2 complex also, in turn, activates the kinase Akt. 11, 12 Thus, Akt lies both upstream and downstream of mTOR. Activation of the mTOR complex mTORC1 mostly induces an anabolic response HIF1 , peroxisome proliferator-activated receptor-(PPAR ), sterol regulatory element-binding proteins (SREBPs) and the transcription factor MYC resulting in synthesis of nucleic acids, proteins, and lipids, 13 and drives processes such as glycolysis and mitochondrial respiration to provide ATP. Activation of mTORC2 also enhances glycolysis via Akt and promotes inactivation of class IIa histone deacetylases, which in turn leads to the acetylation and inactivation of forkhead box protein O1 (FOXO1) and FOXO3, leading to the regulator gene MYC transcription. 8, 14 It is therefore conceivable that leukocyte metabolism may reprogram in response to migratory stimuli and the different environmental cues received during recirculation, as suggested by experimental evidence that we will discuss here.
METABOLIC DEMANDS OF MIGRATING CELLS: METABOLISM AND THE CYTOSKELETON
The eukaryotic cytoskeleton is a complex system of two polymer protein filaments (actin and tubulin) within the cell that confers structural integrity, coordinates the cell cycle and produces motion in response to various stimuli.
Structural integrity results from the cytoskeleton being a robust meshwork extending throughout the cytoplasm. Cellular responses to stimuli result from the cytoskeleton being a highly dynamic structure, in which filaments associate with or dissociate from one another, slide, grow, and shrink, and provide tracks for motor proteins.
Both the actin and microtubule cytoskeletons use energy from nucleotide hydrolysis (ATP in the case of actin and GTP in the case of tubulin) to maintain different assembly and disassembly dynamics at their two ends. 15 We will focus here on the metabolic regulation of actin cytoskeleton rearrangements, The elongation of actin filaments is accompanied by an irreversible hydrolysis of bound ATP and release of inorganic phosphate. 16, 17 ATP molecules are generated via OXPHOS pathway in the mitochondria but also via aerobic glycolysis. The preferential use of glycolysis over OXPHOS for ATP production enables cells to produce ATP at a faster rate. Due to the fact that the energetic yield per molecule of glucose is much lower for aerobic glycolysis (4 moles ATP/mole glucose) than OXPHOS (36 moles ATP/mole glucose), glucose metabolism appears to be an inefficient metabolic pathway. When glucose is abundant, however, the pace of glycolytic flux guarantees a fast availability of ATP molecules. 18 In this context, a large number of studies have reported the interaction of the cytoskeleton with a variety of metabolic enzymes, and in particular those involved in the glycolytic pathway. Interactions with cytoskeletal proteins have been observed for the glycolytic kinases, hexokinase, phosphofructokinase (PFK), and pyruvate kinase (PK) as well as aldolase (reviewed in Ref. 19 ).
Importantly, these interactions can modify enzyme activity. Binding to filamentous actin is known to activate PFK. Recently, it has been shown that insulin signaling increases the association of PFK with actin filaments and it was suggested that this association plays a role in the stimulation of glycolysis by insulin. 20 In serum-depleted cells, the cytoplasmic GAPDH is colocalized with actin stress fibers whereas in the presence of serum, this enzyme is distributed homogeneously. 21 In quiescent cells, aldolase is found along stress fibers whereas in motile cells it is behind the ruffles at the leading edge of the cell. 20 In the presence of fructose-1,6-bisphosphate, a G-actin-aldolase mixture polymerizes to a higher viscosity and forms stiffer filaments than pure actin of the same concentration whilst in permeabilized cells in the presence of fructose-1,6-bisphosphate, aldolase goes from association with actin fibers to association with intermediate filaments. 22 Albeit not yet validated in leukocytes, an elegant model of metabolic (5), or direct activation of glycolitic enzymes (Enzyme X; i, inactive) that localize on the cytoskeleton (6). Here, they promote glycolysis (8) and the local production of ATP molecules required for actin polymerization (9) leading to cell polarization, motility, and invasion. A potential role for the mitochondrial OXPHOS in promoting migration of T cells by providing ATP at the uropod (10) . In this context, GTP-dependent microtubules could contribute to orienting mitochondria within distinct compartments (10) glycolysis takes place in the cytoplasm, thus providing an efficient and rapid source of ATP molecules in proximity of actin polymerization. A model for the metabolic adaptation to migratory stimuli in leukocytes is shown in Fig. 1 .
As we will discuss later, aerobic glycolysis appears to be the main metabolic pathway employed by leukocytes to produce sufficient ATP molecules to support migration.
REGULATION OF METABOLISM BY PROMIGRATORY SIGNALS
The transduction of promigratory signals into metabolic responses has only partly been investigated. 24 Integrins are fundamental for leukocyte anchorage to the vascular wall as well as for leukocyte motility where they mediate force transduction between the substrate and the cytoskeleton enabling cell migration. The effects of integrin-mediated migratory cues on metabolic machineries are well established in cancer cells while evidence that these cues also regulate metabolic pathways of leukocytes is beginning to unfold. 24 Antibody engagement of 5 -integrin resulted in reactive oxygen species production and concomitant mitochondrial membrane depolarization leading to activation of the Rho GTPase Rac and induction of collagenase I expression in fibroblasts. 25 Similarly, the metabolic reprogramming of cancer cells to increase glycolysis and biosynthetic production is controlled by inputs from integrin signaling. 24 Twist is a Helix-Loop-Helix transcription factor involved in the regulation of various physiological processes and in epithelialmesenchymal tumorigenesis transition and cancer metastasis. 26 Twist overexpression in MCF10 breast cancer cells induces a shift to aerobic glycolysis, which requires 1-integrin signaling to activate the focal adhesion kinase (FAK)-PI3K-Akt-mTOR signaling axis. 27 Less is known about the ability of chemokine-induced signals on metabolism. In T cells, CCL5 is able to induce glucose uptake in an mTORC1-dependent manner. 28 CCL5 treatment of ex-vivo activated human T cells also induced the activation of the nutrient-sensing kinase 5 ′ adenosine monophosphate-activated protein kinase (AMPK) and downstream substrates Acetyl-CoA carboxylase (ACC-1), PFKFB-2, and glycogen synthase kinase (GSK)-3. 28 More recently, a PI3K/mTORC2 pathway has been shown to be induced by both integrin and chemokine receptor signals in regulatory T lymphocytes. 29 Collectively, these studies suggest that signaling pathways downstream of integrin and chemokine receptors can directly modulate metabolic pathways (Fig. 1) . [30] [31] [32] [33] Chemotaxis of myeloid cells like other types of cells is also known to require energy in the form of ATP that is produced on demand during migration. ATP is rapidly consumed within the cytosol to fuel the remodeling of the actin cytoskeleton necessary for cell migration. 23, 34 There is evidence to suggest that nutrient availability in the microenvironment can indirectly influence myeloid cell migration.
METABOLIC REGULATION OF MYELOID CELL MIGRATION
For example, macrophages from LDL-receptor-deficient mice showed increased chemotactic activity when exposed to metabolic stress. 35 In a later study by the same group, 36 In addition to migratory capacity of monocyte/macrophages, the ability to rearrange actin cytoskeleton for the purpose of cell spreading, protrusion formation, and phagocytosis of opsonized particles by LPS-stimulated RAW264.7 macrophages has been shown to be largely dependent on glucose supply through glycolysis-induced ATP production. 39 The role of metabolic pathways in phagocyte respiratory burst has been reviewed elsewhere. 40 Compartmentalization of metabolic activities within the cell has also been reported as a molecular mechanism to regulate cytoskeletal reorganization while supporting other cellular functions. In podocytes, specialized myeloid-derived kidney cells, mitochondrial respiration was found to be active in parallel with glycolysis. 41 GSD-Ib patients show immunodeficiency due at least in part to an impairment of mobility and chemotaxis by PMN. 45 In dendritic cells, the enzyme alpha enolase 1, ENO1, was linked to the metabolic shift from oxidative phosphorylation to aerobic glycolysis during Chlamydia infection. 46 The lack of ENO1 was shown to affect the morphology of dendritic cells, and resulted in poor immunogenic potential due to reduced antigen presentation, all of which are functions that are mediated by cytoskeletal rearrangements. 47 
THE METABOLIC MACHINERY AND T LYMPHOCYTE MIGRATION
The regulation of energy metabolism is crucial to T cell-mediated immunity, including activation, proliferation and differentiation. Naïve T cells rely upon a catabolic type of metabolism whereby ATP is mainly generated via OXPHOS. This slow metabolism is sufficient to support their requirements for survival, maintain housekeeping functions, such as ion transport and membrane integrity and keep them away from engaging into cell proliferation. 48, 49 Upon TCR engagement by cognate antigen, T cells switch from catabolism to anabolism.
Phosphatidylinositol 3 ′ -kinase (PI3K) leads to the activation of the serine-threonine kinase AKT, which promotes glucose metabolism by stimulating the localization of the glucose transporter Glut1 to the plasma membrane and the activity of hexokinase and phosphofructokinase, two rate-limiting enzymes of the glycolytic pathway. Increased glycolytic flux enables activated T cells to generate ATP and, at the same time, efficiently utilize carbon sources in the form of amino acids and lipids for the biosynthesis of proteins and membranes necessary for the expansion phase that characterizes the immune response. [50] [51] [52] [53] [54] Downstream of TCR, Akt also controls the activation state of mTOR, a sensor of nutritional and energetic status in cells that promotes protein synthesis. mTOR is a key regulator of T cell differentiation towards proinflammatory subsets, and its inhibition with rapamycin promotes immunosuppression via the induction of anergic and T reg cells. [50] [51] [52] [53] [54] [55] The metabolic machinery is also likely to directly affect and be affected by T cell migratory events, as T cells continuously recirculate between different microenvironments (e.g. blood, lymphoid tissues, and peripheral tissues) in which they are exposed to different nutrient availability and oxygen tension, and must adapt their metabolic pathways to effectively mediate immune responses. Upon resolution of the immune response, the number of antigenspecific T cells contracts, as effector cells die and only the memory subset survive. This step is characterized by a metabolic transition from anabolism to catabolism, from high mTOR activity to low mTOR activity, and from effector to memory cells. 56, 57 This transition is associated with the re-expression of CD62L and CCR7, thus allowing the newly formed memory cells to continue surveillance by trafficking in and out of SLOs. Consistently, rapamycin-mediated inhibition of mTOR causes effector T cells to reexpress CD62L and CCR7, and home to SLOs where they are trapped away from the target sites in the periphery. 56, 57 Therefore, rapamycin can promote immunosuppression by redirecting effector T cells from peripheral tissues to SLOs.
Evidence that T lymphocyte motility is also directly regulated by aerobic glycolysis has also recently emerged.
A role for CCL5-mediated glucose uptake and ATP accumulation to meet the energy demands of chemotaxis in activated T cells has been reported. 28 Similarly, a recent investigation has shown that not only that the glycolytic pathway is required for CXCL10-induced migration of activated T lymphocytes, but also that glycolysis products can modulate T cell motility in vitro and in vivo. 58 A metabolic switch to aerobic glycolysis comprises the upregulation of glycolytic enzymes and glucose transporters to the membrane, leading to an increase in glycolytic flux and the concomitant production of lactate. This carbon molecule has long been considered a metabolic "waste" by-product of highly proliferating cells. Recently, this view has been challenged by the observation that lactate can act as a signaling molecule and provide a "danger" signal. 59, 60 Findings that endothelial cells and human CTL can take up extracellular lactate, 61, 62 that lactate inhibits phosphofructokinase 63 and that exposure to lactate leads to a dramatic change in gene expression in L6 muscle cells 64 have shed light on the complexity and scope of lactate as an active metabolite driving signaling pathways that modulate cell functions. Extracellular sodiumlactate and lactic-acid were shown to inhibit the motility of CD4 + and CD8 + T-cells, respectively, via subset-specific transporters (Slc5a12 and Slc16a1) that are selectively expressed by CD4 + and CD8 + T cells, respectively. 58 Lactate-mediated inhibition of CD4 + T-cell motility is due to an interference with glycolysis activated upon engagement of the chemokine receptor CXCR3 with the chemokine CXCL10. In contrast, the lactic-acid effect on CD8 + T-cell motility was found to be independent of glycolysis control. Importantly, the expression of lac- Glycolysis is also instrumental for regulatory T cell (Treg) migration where it is initiated by pro-migratory stimuli, including LFA-1 and chemokine receptor signalling. 29 However, unlike in conventional T cells, in which migration is dependent upon mTORC1-induced glycolysis, migration of Treg is sustained by a PI3K-mTORC2-mediated pathway culminating in the induction of the enzyme glucokinase (GCK).
Subsequently, GCK fuels actin recombination by co-localizing with a pump ATPase on the cytoskeleton. Tregs lacking this pathway are functionally suppressive but unable to localize to skin allografts and prolong their survival. Similarly, human carriers of a loss-of-function mutation in the GCK regulatory protein gene-leading to increased GCK activity-have decreased numbers of circulating activated Tregs, which display enhanced migratory activity, while their suppressive function and conventional T cells are unaffected. 29 Thus, a specific metabolic response regulates Treg migration.
In addition to the emerging function of glycolysis in promoting T lymphocyte motility, a role for the mitochondrial OXPHOS has been suggested by an elegant in vitro study, showing that mitochondria specifically concentrate at the uropod during lymphocyte migration and that glycolytic T cells require mitochondrial ATP production at the uropod to migrate. 65 Cytoskeletal components are known to polarize during T-cell migration. 66 The leading edge, at the advancing front of the cell, is the site where -actin and the chemokine receptors that are responsible for detection of the chemoattractant gradient are concentrated, while the uropod at the trailing edge contains the motor protein myosin II and a meshwork of microtubules directed from a microtubuleorganizing center. 66 Intracellular distribution of mitochondria is controlled by their movement along microtubules, mediated by kinesin and dynein motors. 67, 68 It is possible that the close interactions of these organelles with microtubules might provide a convenient source of ATP and GTP--the latter used for tubulin polymerization, for cytoskeleton reorganization, at the uropod.
Collectively, these observations open the possibility that distinct cytoskeletal components preferentially utilize different metabolic pathways to generate the energy required for migration. Although very interesting, the biological significance of "polarization" of OXPHOS during migration remains to be established.
Most of these studies have been carried out on activated T lymphocytes. Naïve T cells continuously recirculate from blood through secondary lymphoid tissue and rely upon OXPHOS to generate energy in order to meet the basic needs of cellular function and survival. 69 However, the metabolic demands of migrating naïve T lymphocytes remain to be investigated.
PHYSIOLOGICAL AND PATHOLOGICAL SIGNIFICANCE OF METABOLIC REGULATION OF LEUKOCYTE MIGRATION
The role of metabolism in directing the fate of immune cells and their activation potential in an inflammatory microenvironment is a relatively new field, but one that is attracting a substantial amount of interest. One important message to take home is that both systemic and intracellular metabolism can profoundly influence the functional properties of immune cells both in resting as well as activated state. [30] [31] [32] [33] On the other hand, altering metabolism within the immune cells can indirectly affect the immediate microenvironment. In hypoxic macrophages, a stress protein regulated in development and DNA damage responses 1 (REDD1), is upregulated in response to an increase in HIF1 , and has a crucial role in inhibiting mTORC1.
Wenes et al. 70 shown how these are modified by increasing hypoxic and glycolytic conditions imposed by cancer cells. 30, 33, 72, 73 Apart from the pathophysiological conditions within the tumor microenvironment, altered metabolism in immune cells can be triggered through other systemic metabolic alterations including western diet, diabetes, and dyslipidaemias, all of which are discussed in-depth by Norata and colleagues. 30 The impact of systemic metabolic alterations on leukocyte migration however, is less elucidated and requires more research. Hyperlipidaemia for example has deleterious effects on the chemotaxis of blood monocytes. 74 In ldlr −/-mice, blood monocytes showed intracellular accumulation of neutral lipids leading to deregulated signaling by the small GTPase Ras homolog gene family member A (RhoA) and cytoskeletal rearrangements leading to a defect in recruitment to the inflamed peritoneum. In addition, a recent report has shown that a relatively short-term exposure to high fat diet results in biased differentiation of proinflammatory effector memory T lymphocytes, which preferentially localize to nonlymphoid tissue. 75 All the above studies suggest that targeting systemic metabolism reprograms immune cell function and phenotype resulting in a beneficial therapeutic potential. 30, 72 
CONCLUSIONS
Recent years have seen an exponential expansion of the relatively new field of immunometabolism. While metabolic reprogramming and adaptation have been largely defined in leukocyte cellular division and differentiation, there is limited but strong evidence that specific metabolic pathways and mediators are fundamental for the ability of leukocytes to migrate. Overall, the few studies available-which we have summarized here-overwhelmingly point to aerobic glycolysis as the key pathway required for migration. As discussed, aerobic glycolysis is well suited for the supply of ATP molecules in rapid cellular responses, such as reorganization of the actin cytoskeleton. Additionally, this pathway can be promptly activated when cells become exposed to low oxygen tension, such as during leukocyte migration from the blood into tissues. Importantly, as summarized in Fig. 2 
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